These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 23398869

  • 1. Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward?
    Ruhe J, Mildvan D.
    Infect Dis Clin North Am; 2013 Mar; 27(1):115-32. PubMed ID: 23398869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR, Lemonovich TL.
    Am Fam Physician; 2011 Jun 01; 83(11):1299-306. PubMed ID: 21661712
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT, Arfstrom RJ, Mihalovic SW, Dababneh AS, Varatharaj Palraj BR, Dierkhising RA, Mara KC, Lessard SR.
    Am J Ther; 2020 Jun 01; 27(2):e177-e182. PubMed ID: 30418221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
    Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M.
    Int J Antimicrob Agents; 2023 Sep 01; 62(3):106905. PubMed ID: 37385561
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
    File TM.
    J Manag Care Pharm; 2009 Mar 01; 15(2 Suppl):S5-11. PubMed ID: 19236135
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia.
    Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG.
    JAMA Pediatr; 2017 Dec 01; 171(12):1184-1191. PubMed ID: 29084336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
    Teh B, Grayson ML, Johnson PD, Charles PG.
    Clin Microbiol Infect; 2012 Apr 01; 18(4):E71-3. PubMed ID: 22284533
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibiotic treatment outcomes in community-acquired pneumonia.
    Çilli A, Sayıner A, Çelenk B, Şakar Coşkun A, Kılınç O, Hazar A, Aktaş Samur A, Taşbakan S, Waterer GW, Havlucu Y, Kılıç Ö, Tokgöz F, Bilge U.
    Turk J Med Sci; 2018 Aug 16; 48(4):730-736. PubMed ID: 30119147
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.